SKI Market

Indian Indices

Sensex

82,814.71 316.57
( 0.38%)

Global Indices

Nasdaq

49,649.56 233.39
(0.47%)

Dow Jones

6,930.29 47.40
(0.69%)

Hang Seng

56,838.27 -629.56
(-1.10%)

Nikkei 225

10,691.66 64.62
(0.61%)

Forex

USD-INR

90.70 0.01
(0.01%)

EUR-INR

107.23 -0.14
(-0.13%)

GBP-INR

122.83 -0.27
(-0.22%)

JPY-INR

0.59 0.00
(-0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

210.31

46.94

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

Bannari Amman Sugars standalone net profit rises 67.96% in the December 2025 quarter

Feb 06,2026

Net profit of Bannari Amman Sugars rose 67.96% to Rs 48.39 crore in the quarter ended December 2025 as against Rs 28.81 crore during the previous quarter ended December 2024. Sales rose 52.84% to Rs 644.11 crore in the quarter ended December 2025 as against Rs 421.43 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	644.11	421.43	53
OPM %	12.84	14.57	-
PBDT	87.82	58.76	49
PBT	72.53	44.58	63
NP	48.39	28.81	68

82,814.71 316.57 ( 0.38%)

49,649.56 233.39 (0.47%)

6,930.29 47.40 (0.69%)

56,838.27 -629.56 (-1.10%)

10,691.66 64.62 (0.61%)

90.70 0.01 (0.01%)

107.23 -0.14 (-0.13%)

122.83 -0.27 (-0.22%)

0.59 0.00 (-0.51%)